P08.19 Resistance towards the MDM2 inhibitor idasanutlin is mediated via the NFkB pathway and IGFBP1 upregulation in glioblastoma

Background: Dysregulation of p53 pathway is common in glioma. Frequent causes are p53 mutations or overexpression of the oncogene MDM2 in p53 wildtype tumors. Idasanutlin is a MDM2 inhibitor, which is currently under investigation for multiple myeloma and acute myeloid leukemia, but of principal int...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Hertenstein, A., Chiblak, S., Hielscher, T., Ciprut, S., Lemke, D., Thomé, C., Kessler, T., Abdollahi, A., Platten, M., Wick, W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
POSTER PRESENTATIONS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463780/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.209
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller